GovChime
IDVSmall business

IDC (single-award IDV) 75N95023D00019ALTASCIENCES CLINICAL KANSAS INC

Overview

Award facts

Obligated on orders under this IDV
$5.21M
$5,206,922 across 3 orders
Period of performance
From Sep 25, 2023
Modifications
0
Latest action Sep 22, 2023
Contract type
IDC (single-award IDV)
PIID 75N95023D00019

Description of requirement

PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. SEPTEMBER 25, 2023 TO SEPTEMBER 24, 2028. N01DA-23-8935.

Dates and value

Award date
Signed on Sep 22, 2023
Ordering period ends
Sep 24, 2028
Ceiling
Ceiling (single-award vehicle): $21,000,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Sep 22, 2023. View on USAspending · Recipient on SAM.gov

Recipient

NameALTASCIENCES CLINICAL KANSAS INC
LocationOVERLAND PARK, KS
UEIWZ5RGEMMQ3W9
CAGE code6PS73
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyALTASCIENCES CLINICAL KANSAS INC.

Business types and certifications

For-profit organizationCorporation (not tax-exempt)

Self-reported at the time of the action.

Agency and place

Awarding and funding

Awarded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA
Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NATIONAL INSTITUTES OF HEALTH NIDA

Classification and competition

Classification

NAICS
541715RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
Product or service (PSC)
AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH (research and development)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
75N95023R00002
Solicitation date
Nov 3, 2022
Notices

Contract details

Subcontracting plan
Plan not requiredB
Major program
Pharmacokinetic and pharmacodynamic trials for medication development in sud
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Service Contract Act labor standards
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Transaction history

Modification history

Base award
Sep 22, 2023
Latest action
Sep 22, 2023 — Base awardModification 0
Actions by type
  • Base award1
1 actions recorded, Sep 22, 2023 to Sep 22, 2023; each action counted once.

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No

Pricing and financing

Latest action: change in base and all options
$21,000,000

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
Clinger-Cohen Act planning (IT)
No
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA

Structure

Award or IDV
IDV
IDV type
IDCB
Indefinite-delivery contract type
Indefinite delivery / indefinite quantityB
Multiple or single award
Single awardS
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N950
Transactions recorded under this award key
1

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N950